Tag: Valeant pharma Q2 loss widens on weak revenues

Valeant pharma Q2 loss widens on weak revenues

byCT Report

09/08/2016

LONDON: Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) reported Tuesday that its second-quarter net loss was $302.3 million or $0.88 per ...

No Result

View All Result

Transfers and Postings
Latest News
Karachi
Islamabad
Lahore
National
Chambers & Associations
Business
Contact us
About Us

Tag: Valeant pharma Q2 loss widens on weak revenues

Valeant pharma Q2 loss widens on weak revenues

Popular Stories

FBR, Pakistan Customs express concerns over recent transfers & postings

Lahore Appraisement foils bid to smuggle goods, items worth Rs1.36b

MTBA seeks action for early disposal of pending cases in ATIR

FBR introduces SMS service 9966 to facilitate taxpayers

PM Shehbaz directs FBR to defer implementation of SRO 350